These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7298774)

  • 1. Simultaneous determination of misonidazole and desmethylmisonidazole in plasma by high-performance liquid chromatography.
    Meering PG; Maes RA
    J Chromatogr; 1981 Oct; 225(2):407-15. PubMed ID: 7298774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of misonidazole and desmethylmisonidazole in plasma by high-performance liquid chromatography with reductive electrochemical detection.
    Meering PG; Baumann RA; Zijp JJ; Maes RA
    J Chromatogr; 1984 Sep; 310(1):159-66. PubMed ID: 6501511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample preparation and a liquid chromatographic assay for misonidazole and desmethylmisonidazole.
    Hubbard RW; Beierle FA
    J Chromatogr; 1982 Nov; 232(2):443-9. PubMed ID: 7153294
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse.
    Malmary-Nebot MF; Labat C; Terrissol M; Martin B; Oustrin J
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):17-20. PubMed ID: 7067719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography.
    Toraño JS; Vermes A; Guchelaar HJ
    Biomed Chromatogr; 2001 Apr; 15(2):89-94. PubMed ID: 11268048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of misonidazole.
    Notter G; Rylander U; Turesson I
    Strahlentherapie; 1980; 156(10):714-8. PubMed ID: 7434379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man.
    Bleehen NM; Grant RM; Jones DH; Roberts JT; Workman P; Gleave JR; Hardy DG; Holmes AE
    Br J Radiol; 1983 Nov; 56(671):859-63. PubMed ID: 6626877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous determination of verapamil and its major metabolite in human plasma by high performance liquid chromatography].
    Tan L; Yang SR; Liu XQ; Yuan YS
    Yao Xue Xue Bao; 1995; 30(9):689-93. PubMed ID: 8701745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K; Begg E; Wade D; O'Shea K
    Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL; Paterson IC; Newman H; Venables S
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
    Hirst DG; Hazlehurst JL; Brown JM
    Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assay of a radiation-sensitizer, misonidazole, by high-performance liquid chromatography].
    Diquet B; Colin JN; Bonnat C; Singlas E
    Ann Pharm Fr; 1983 Feb; 40(5):459-64. PubMed ID: 6847079
    [No Abstract]   [Full Text] [Related]  

  • 15. The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.
    Rose GP; Taylor JM
    Toxicology; 1985 Jan; 34(1):43-56. PubMed ID: 3918357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the O-demethylation of misonidazole by rat liver microsomes.
    Shoemaker DD; McManus ME; Hoerauf R; Strong JM
    Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatography.
    Marques RA; Stafford B; Flynn N; Sadée W
    J Chromatogr; 1978 Jul; 146(1):163-6. PubMed ID: 670352
    [No Abstract]   [Full Text] [Related]  

  • 18. Automated high-performance liquid chromatographic method for the determination of mianserin in plasma using electrochemical detection.
    Brown LW; Hundt HK; Swart KJ
    J Chromatogr; 1992 Nov; 582(1-2):268-72. PubMed ID: 1491054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection.
    Chu SY; Sennello LT; Sonders RC
    J Chromatogr; 1991 Nov; 571(1-2):199-208. PubMed ID: 1839793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance liquid chromatographic determination of clocapramine in feed and plasma.
    Geahchan A; Chambon P; Genoux P
    J Assoc Off Anal Chem; 1982 May; 65(3):706-10. PubMed ID: 6124530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.